Titan Medical names Perry A. Genova VP, research and development
Dr. Genova is a recognized expert in medical device product development and has published 32 peer-reviewed papers and been issued 30 U.S. Patents, with another 24 U.S. patents pending.
Dr. Genova is an accomplished biomedical engineering executive recognized for building and leading successful teams in medical device product development in small and multi-national companies in the U.S. and Europe.
Prior to joining Titan, Dr. Genova was with Durham, NC Centauri Robotic Surgical Systems, Inc., a privately-held developer of a disruptive surgical robot for stereotactic neurosurgery.
Prior to Centauri he was President and CEO of Oncoscope, Inc., a medical device company that developed a non-invasive light-based cancer diagnostic, which was acquired by SpectraScience in 2016.
Dr. Genova received a PhD in Biomedical Engineering from The University of North Carolina at Chapel Hill, a Master’s Degree in Biomedical Engineering from The University of North Carolina at Chapel Hill, and a Bachelor’s Degree in Electrical Engineering from The University of North Carolina at Charlotte. ■
LATEST MOVES FROM Ontario
- Trillium Therapeutics appoints Helen Tayton-Martin to board
- Impopharma appoints key managers
- TD Bank Group appoints Ajai Bambawale as CRO
- United Van Lines (Canada) names Dan Lawrence president
- Jamieson Wellness appoints Angela Holtham to board
More inside POST